Search results
As earnings season begins, major companies' performance reports to decide market movement in coming...
Business Insider India· 5 days ago) is set to announce its first-quarter performance results on Thursday. In its previous earnings...
Carbon trading regime is yet to kick in, but the voluntary market is buzzing
Livemint· 3 days agoAround two dozen renewable energy producers sell these certificates, while buyers include...
Elon Musk's Neuralink says tiny wires of brain chip in first patient now stable
The Economic Times· 5 days agoThe tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable ...
Audit panels of companies should step up engagement with auditors: NFRA chief Ajay Bhushan Prasad...
The Economic Times· 4 days agoAudit panels of companies, comprising mostly independent directors, need to deepen their engagement...
Unstop & Flipkart is back with the Flipkart GRiD 6.0; this year, it's bigger and better!
SiliconIndia· 4 days agoGRiD 6.0, which provides students with the opportunity to find innovative solutions to real-world problems and hone their technical skills and knowledge, is now bigger and better, as it will ...
AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
Pharmaceutical Technology· 4 hours agoGlobalData is the parent company of Pharmaceutical Technology. Rinvoq’s regulatory submissions are...
AWS Teams Up with Accel to Support GenAI Startups in APJ – AIM
Analytics India Magazine· 13 hours agoThe AWS Generative AI Spotlight program will select up to 120 early-stage startups across the region, including 40 from India.
Swastika Investmart Ltd Stock Price: Swastika Investm Share Price Today | India Infoline
India Infoline· 16 hours agoThe Company is also involved in the field of Hire Purchase and Lease Finance.
Lexeo gene therapy shows signs of heart benefit in small study
BioPharma Dive· 10 hours agoThe biotech, which went public late last year, argued the results justify exploring an accelerated...
Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data
BioPharma Dive· 9 hours agoUpdated results show the biotech's RAS inhibitor shrank pancreatic tumors in 20% to 25% of study ...